173 related articles for article (PubMed ID: 7694550)
21. [Inherited abnormalities of the epidermis caused by mutation of keratins].
Hohl D
Ann Dermatol Venereol; 1995; 122(4):162-6. PubMed ID: 8526410
[TBL] [Abstract][Full Text] [Related]
22. Suppression of keratin 15 expression by transforming growth factor beta in vitro and by cutaneous injury in vivo.
Werner S; Munz B
Exp Cell Res; 2000 Jan; 254(1):80-90. PubMed ID: 10623468
[TBL] [Abstract][Full Text] [Related]
23. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
24. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
Go C; Li P; Wang XJ
Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.
Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J
Oncogene; 1997 Apr; 14(14):1725-34. PubMed ID: 9135074
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
[TBL] [Abstract][Full Text] [Related]
27. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
28. Keratins and skin disorders.
Rao KS; Babu KK; Gupta PD
Cell Biol Int; 1996 Apr; 20(4):261-74. PubMed ID: 8664850
[TBL] [Abstract][Full Text] [Related]
29. Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.
Mann A; Breuhahn K; Schirmacher P; Wilhelmi A; Beyer C; Rosenau A; Ozbek S; Rose-John S; Blessing M
Cancer Res; 2001 Mar; 61(5):2311-9. PubMed ID: 11280804
[TBL] [Abstract][Full Text] [Related]
30. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
[TBL] [Abstract][Full Text] [Related]
31. The keratins and their disorders.
Rugg EL; Leigh IM
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):4-11. PubMed ID: 15452838
[TBL] [Abstract][Full Text] [Related]
32. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
[TBL] [Abstract][Full Text] [Related]
33. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
34. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
[TBL] [Abstract][Full Text] [Related]
35. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Bsk mice: I. The Bsk mutation does not involve a recombination of cornea-specific keratin 12 and skin-specific hair keratin genes.
Shiraishi A; Kao CW; Ishizaki M; Zhang Z; Converse RL; Tseng SC; Svoboda KK; Kao WW
Curr Eye Res; 1998 May; 17(5):531-40. PubMed ID: 9617549
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
38. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
39. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter.
Bailleul B; Surani MA; White S; Barton SC; Brown K; Blessing M; Jorcano J; Balmain A
Cell; 1990 Aug; 62(4):697-708. PubMed ID: 1696852
[TBL] [Abstract][Full Text] [Related]
40. Human keratin 14 driven HPV 16 E6/E7 transgenic mice exhibit hyperkeratinosis.
Kim SH; Kim KS; Lee EJ; Kim MO; Park JH; Cho KI; Imakawa K; Hyun BH; Chang KT; Lee HT; Ryoo ZY
Life Sci; 2004 Nov; 75(25):3035-42. PubMed ID: 15474555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
